196 related articles for article (PubMed ID: 21800826)
1. Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.
Al-Horani RA; Liang A; Desai UR
J Med Chem; 2011 Sep; 54(17):6125-38. PubMed ID: 21800826
[TBL] [Abstract][Full Text] [Related]
2. Designing small, nonsugar activators of antithrombin using hydropathic interaction analyses.
Gunnarsson GT; Desai UR
J Med Chem; 2002 Mar; 45(6):1233-43. PubMed ID: 11881992
[TBL] [Abstract][Full Text] [Related]
3. Interaction of designed sulfated flavanoids with antithrombin: lessons on the design of organic activators.
Gunnarsson GT; Desai UR
J Med Chem; 2002 Sep; 45(20):4460-70. PubMed ID: 12238925
[TBL] [Abstract][Full Text] [Related]
4. On designing non-saccharide, allosteric activators of antithrombin.
Raghuraman A; Liang A; Krishnasamy C; Lauck T; Gunnarsson GT; Desai UR
Eur J Med Chem; 2009 Jun; 44(6):2626-31. PubMed ID: 18996625
[TBL] [Abstract][Full Text] [Related]
5. Exploring new non-sugar sulfated molecules as activators of antithrombin.
Gunnarsson GT; Desai UR
Bioorg Med Chem Lett; 2003 Feb; 13(4):679-83. PubMed ID: 12639557
[TBL] [Abstract][Full Text] [Related]
6. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
Futamura A; Beechem JM; Gettins PG
Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
[TBL] [Abstract][Full Text] [Related]
7. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin activation by nonsulfated, non-polysaccharide organic polymer.
Monien BH; Desai UR
J Med Chem; 2005 Feb; 48(4):1269-73. PubMed ID: 15715496
[TBL] [Abstract][Full Text] [Related]
9. Hydropathic interaction analyses of small organic activators binding to antithrombin.
Gunnarsson GT; Desai UR
Bioorg Med Chem; 2004 Feb; 12(3):633-40. PubMed ID: 14738974
[TBL] [Abstract][Full Text] [Related]
10. Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.
Henry BL; Connell J; Liang A; Krishnasamy C; Desai UR
J Biol Chem; 2009 Jul; 284(31):20897-908. PubMed ID: 19497853
[TBL] [Abstract][Full Text] [Related]
11. Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.
Rashid Q; Singh P; Abid M; Jairajpuri MA
J Thromb Thrombolysis; 2012 Aug; 34(2):251-9. PubMed ID: 22453684
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
Lin P; Sinha U; Betz A
Biochim Biophys Acta; 2001 Apr; 1526(1):105-13. PubMed ID: 11287128
[TBL] [Abstract][Full Text] [Related]
13. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
14. Importance of lysine 125 for heparin binding and activation of antithrombin.
Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
[TBL] [Abstract][Full Text] [Related]
15. Helix D elongation and allosteric activation of antithrombin.
Belzar KJ; Zhou A; Carrell RW; Gettins PG; Huntington JA
J Biol Chem; 2002 Mar; 277(10):8551-8. PubMed ID: 11741963
[TBL] [Abstract][Full Text] [Related]
16. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
[TBL] [Abstract][Full Text] [Related]
17. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
[TBL] [Abstract][Full Text] [Related]
18. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
Arocas V; Turk B; Bock SC; Olson ST; Björk I
Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition.
Rashid Q; Abid M; Jairajpuri MA
J Nat Sci Biol Med; 2014 Jan; 5(1):36-42. PubMed ID: 24678194
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide.
Wiebe EM; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2003 Sep; 278(37):35767-74. PubMed ID: 12832413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
